The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

Details

• Alternative Title:
  J Addict Med
• Corporate Authors:
  Clinical Guideline Committee (CGC) Members BatkiStevenMDCiccaroneDanielMD, MPHHadlandScott E.MD, MPHHurleyBrianMD(Co-Chair)KabernagelKimberlyDOLevinFrancesMDMcKayJamesPhDMooneyLarissaMD(Co-Chair)PuriSiddarthMDSaxonAndrewMDSevarinoKevinMD, PhDSimonKevinMDWiegandTimothyMD ; ASAM Team BoyleMaureenPhDDevotoAmandaPhDSafarianTaleen ; AAAP Team DirstMichelle ; IRETA Team LindsayDawnPhDLincolnPiperMSHelmickJillianLuongoPeterPhD
• Description:
  The American Society of Addiction Medicine/American Academy of Addiction Psychiatry (ASAM/AAAP) Clinical Practice Guideline on the Management of Stimulant Use Disorder provides guidance on evidence-based strategies for the treatment of stimulant use disorders (StUDs), stimulant intoxication, and stimulant withdrawal, as well as secondary and tertiary prevention of harms associated with stimulant use. The Clinical Guideline Committee (CGC) comprised experts from ASAM and AAAP representing a range of clinical settings and patient populations. The guideline was developed following modified GRADE methodology. The process included a systematic literature review as well as several targeted supplemental searches. The CGC utilized Evidence to Decision tables to review available evidence and rate the strength of each recommendation. The clinical practice guideline was revised based on external stakeholder review. Key takeaways included: Contingency management represents the current standard of care for treatment of StUDs; Pharmacotherapies may be utilized off-label to treat StUDs; Acute stimulant intoxication can result in life-threatening complications that should be addressed in an appropriate level of care; Secondary and tertiary prevention strategies should be used to reduce harms related to risky stimulant use.
• Subjects:
  • Amphetamine-Related Disorders
  • Central Nervous System Stimulants
  • Humans
  • Substance-Related Disorders
• Keywords:
  • Stimulant Use Disorder
  • Clinical Guideline
  • Addiction Treatment
  • Stimulant Intoxication
  • Prevention
• Source:
  J Addict Med. 18(1):1-56
• Pubmed ID:
  38669101
• Pubmed Central ID:
  PMC11105801
• Document Type:
  Text
• Funding:
  75D30121P11598/ImCDC/Intramural CDC HHSUnited States/ ; HHSN271201600056C/DA/NIDA NIH HHSUnited States/ ; HHSN271201700032C/DA/NIDA NIH HHSUnited States/ ; R01 DA054190/DA/NIDA NIH HHSUnited States/
• Genre:
  Journal Article
• Volume:
  18
• Issue:
  1
• Download URL:
  https://stacks.cdc.gov/view/cdc/156927/cdc_156927_DS1.pdf
• File Type:
  [PDF - 903.32 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:0a1c4021c2dc9d90c038191c6ee4fe44db1abc3d2747484d4252878cb62b09bfc8d097c12f11de889b604c04ac3a25d9a8c1a774c5b4123e60f7e269e6891491